PacBio announced a collaboration with the University Hospital of Munster, to use long-read whole genome sequencing to significantly advance male infertility and rare disease research. By deploying PacBio’s Revio HiFi sequencing system, researchers at Munster will obtain highly accurate genomic data essential for addressing complex genetic issues associated with male infertility, including the Y chromosome.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PACB:
- PacBio price target lowered to $7 from $8 at Scotiabank
- PacBio to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
- PacBio price target lowered to $2.50 from $3.50 at Stephens
- PacBio price target lowered to $2 from $4 at Morgan Stanley
- PacBio price target lowered to $3 from $3.50 at Canaccord